Quintix: New Sartorius Lab Balance Redefines the Meaning of Easy for Standard Lab Applications
Sartorius has launched a user-friendly, highly accurate standard laboratory balance on the market: Quintix. Its intuitive operating design guides users fast with fail-safe confidence through the many weighing applications built into the balance, helping to enhance laboratory workflows. The new Sartorius lab balance is available in a choice of 12 models with weighing capacities ranging from 220 g to 5100 g and readabilities extending from 0.1 mg to 1 g.
User-Friendly Weighing Applications
The user interface of the Sartorius Quintix balance was developed by Sartorius in teamwork with experienced lab users. All applications are shown as self-explanatory icons on the Quintix touch screen and can be precisely selected even when the user is wearing lab gloves. The balance guides the user step by step through each weighing process, thus preventing operating errors. Quintix features built-in applications that include weighing in percent, weighing under unstable conditions and weighing components; counting, mixing, checkweighing; peak hold to determine the highest measurement in a series; density determination; statistics and conversion.
Automatic Calibration and Adjustment with isoCAL
Temperature fluctuations affect the accuracy of weighing results. This is why balances must be calibrated and adjusted at regular intervals as soon as ambient conditions change. The isoCAL combined calibration and adjustment function on the Quintix alerts the user whenever a defined time or temperature limit has been exceeded and adjusts the balance automatically using an internal weight. Moreover, the Cal Audit Trail function documents every calibration and adjustment operation for 100% traceability in quality assurance.
Fully Traceable GLM- and GMP-Compliant Documentation
All advanced laboratories today must provide GLP- and/or GMP-compliant documents and further process weighing data quickly and reliably. The Quintix balance transfers its data directly over its built-in USB port to any computer in the lab, without requiring any additional software. As a result, weighing data can be easily and rapidly read into Excel or into any other program for further processing.
The Highest Metrological Accuracy Ensured by Technology “Made in Germany”
The Sartorius Quintix balance has been put through its paces in more than 1,000,000 stress tests involving repeatability, linearity and temperature drift. Therefore, the balance guarantees the highest metrological quality and reliability of its weighing results.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance